PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

Clinical trial NCT01212770 · COMPLETED

Trial details

NCT number: NCT01212770
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2010-09-30
Primary completion: 2012-08-21
Enrollment: 505

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.